AI’s potential to accelerate drug discovery needs a reality checkClose bannerClose banner
TechBio Unicorn Owkin Teams Up with AWS to Advance Generative AI for Precision MedicineFacebookGoogle PlusInstagramMail ToLinkedInPinterestQuotation MarkTumblrTwitterYoutubeRSSmagnifygreater thanQuoteCloseSearchRight arrowIcon for read more (cta)Download I
Business Operations Lead, gCS Machine Learning for Drug Discovery (MLDD) in South San Francisco, California, United States of America | Business Strategy & Delivery at Genentech
Artificial Intelligence in Drug Discovery Market CAGR of 27.5%
Customer service vs. customer experience: Key differentiators
Enhancing Digital Performance through End-to-End Observability | by Sameer Paradkar | Oolooroo | Feb, 2024 | Medium
Mechanical and Manufacturing Engineering | BGSU
Scientist, Process Development | Norwood, Massachusetts | Moderna
PET Chemist (Head of Production and QP per 2018/2019) at St Olavs Hospital, Senior Consultant at VikingPharmaMiddel
Joined 05/19/2017
Level: LEVEL 01 (12 mo pts: 0 pts)
Lifetime points: 5 pts
PhD in aqueous nanotechnology, synthetic organic chemist since 1991 within biotech: R&D and pharmaceutical API development. My experience is i.e. 15 years as (Sr) scientist, R&D leader and groupleader. I worked in a CRO where I was project leader/owner for i.e. the 10 largest API producers worldwide. Basic synthetic R&D in discovery, was followed by scale-up and GMP-prosess developments, tech-transfer and patenting. I validated API processes up to three tonns production batches. This included many analytical projects, isotope labelling, 13C, D, 15N, 18F. I participated in auditing and developed and maintained B2B cont(r)acts. I successfully wrote many R&D proposals and initiated R&D for newly established companies or the pharma top 10. Several compounds and or formulations (from libraries) went past the patenting phase. One is marketted as an API and one as an OTC.
I continued my CRO work in Norway at Caliber AS. Three following years at Weifa AS performing GMP process development for subutex/buprenex/buprenorphine, codeine phosphate, metformin, discovery and product dev, GMP process maintanance. In BASF I was temporary hired to support the R&D development of their new OTC omega-3 product and their fase-III API R&D.
Jeg hadde ansvar til oppfølging og etablering av CRO-CMO forhold som konsulent, i GMP prosess oppstart og utvikling. Batch produksjon til første kliniske forsøk. Min største kompetanse ligger i FoU forskning, lede prosjekter innen Pharma, nyskapning og forenkling av kjemisk utvikling for å komme seg til passende og lønnsomme resultater og til et brukbart prosess til neste GMP steg i utvikling. Stoffer: fargestoffer, steroider, opiater, porfyriner, sukker derivater. Jeg opplærte studenter, biologi, kjemi, og farmasi i basis i organisk kjemi i 7 år og veiledet Bachelor- og Masters oppgaver. Jeg jobbet på tre PET sentere; Groningen, Oslo og Trondheim hvor jeg jobber som kjemiker.
close
Pitch an Idea
In 20 seconds, make an introduction, an ask, a pitch, a question,
or invite others to collaborate with you on a related topic.
Edit your Comment